JPH0341447B2 - - Google Patents

Info

Publication number
JPH0341447B2
JPH0341447B2 JP57158240A JP15824082A JPH0341447B2 JP H0341447 B2 JPH0341447 B2 JP H0341447B2 JP 57158240 A JP57158240 A JP 57158240A JP 15824082 A JP15824082 A JP 15824082A JP H0341447 B2 JPH0341447 B2 JP H0341447B2
Authority
JP
Japan
Prior art keywords
dopa
composition
decarboxylase inhibitor
controlled release
hydrocolloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57158240A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5857315A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5857315A publication Critical patent/JPS5857315A/ja
Publication of JPH0341447B2 publication Critical patent/JPH0341447B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP57158240A 1981-09-14 1982-09-13 製薬学的調製物 Granted JPS5857315A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14
US301498 1981-09-14

Publications (2)

Publication Number Publication Date
JPS5857315A JPS5857315A (ja) 1983-04-05
JPH0341447B2 true JPH0341447B2 (enrdf_load_stackoverflow) 1991-06-24

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57158240A Granted JPS5857315A (ja) 1981-09-14 1982-09-13 製薬学的調製物

Country Status (11)

Country Link
JP (1) JPS5857315A (enrdf_load_stackoverflow)
AT (1) AT385199B (enrdf_load_stackoverflow)
BE (1) BE894376A (enrdf_load_stackoverflow)
BG (1) BG60526B2 (enrdf_load_stackoverflow)
CH (1) CH652025A5 (enrdf_load_stackoverflow)
DE (1) DE3232873A1 (enrdf_load_stackoverflow)
FR (1) FR2512676B1 (enrdf_load_stackoverflow)
GB (1) GB2105590B (enrdf_load_stackoverflow)
IT (1) IT1158048B (enrdf_load_stackoverflow)
MX (1) MX9203173A (enrdf_load_stackoverflow)
NL (1) NL190746C (enrdf_load_stackoverflow)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
DE3642668A1 (de) * 1986-12-13 1988-06-23 Kamprad Joachim Schmerzmittel fuer menschen
ES2052681T5 (es) * 1987-12-31 1997-12-01 Asta Medica Ag Combinacion sinergica de inhibidores de descarboxilasa y granulos de l-dopa.
EP0497977B1 (en) * 1989-10-26 1995-03-15 Nippon Shinyaku Company, Limited Gastric preparation
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
EP0725626A1 (en) * 1993-10-29 1996-08-14 RECKITT & COLMAN PRODUCTS LIMITED Gelatin capsule fill able to foam
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
AU2003282603A1 (en) * 2002-10-11 2004-05-04 Depomed Development Ltd Gastro-retentive levodopa delivery form
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
USD627230S1 (en) 2008-05-22 2010-11-16 Colgate-Palmolive Company Container
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
USD673861S1 (en) * 2012-03-28 2013-01-08 S.C. Johnson & Son, Inc. Dispensing system
DE102014003744A1 (de) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Produkt zur oralen Verabreichung bei Menschen oder Tieren mit mikrostrukturierten, gekapselten Inhaltsstoffen sowie Vorrichtung zum Herstellen eines derartigen Produkts und Verfahren zum Herstellen dieses Produkts
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (de) * 1961-06-16 1966-03-31 Hoffmann La Roche Verfahren zur Herstellung von substituierten Hydrazinen
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
ATA341582A (de) 1987-08-15
MX9203173A (es) 1992-07-01
IT8223147A0 (it) 1982-09-07
GB2105590B (en) 1985-05-30
DE3232873A1 (de) 1983-03-31
NL190746C (nl) 1994-08-01
CH652025A5 (de) 1985-10-31
FR2512676A1 (fr) 1983-03-18
FR2512676B1 (fr) 1987-01-23
AT385199B (de) 1988-02-25
GB2105590A (en) 1983-03-30
NL8203343A (nl) 1983-04-05
IT1158048B (it) 1987-02-18
NL190746B (nl) 1994-03-01
BG60526B2 (bg) 1995-07-28
JPS5857315A (ja) 1983-04-05
BE894376A (fr) 1983-03-14

Similar Documents

Publication Publication Date Title
US4424235A (en) Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
JPH0341447B2 (enrdf_load_stackoverflow)
US4126672A (en) Sustained release pharmaceutical capsules
US4140755A (en) Sustained release tablet formulations
KR100446366B1 (ko) 서트랄린 염 및 서트랄린의 서방성 투여형
AU764346B2 (en) Pharmaceutical composition for the treatment of acute disorders
JP4074675B2 (ja) トラマドール又はトラマドール塩の急速に崩壊する薬剤形
CA1073358A (en) Sustained release formulations
EP0313328A1 (en) Sustained-release formulations
US20110142931A1 (en) Soft tablet containing dextrose monohydrate
CA2330480C (en) Controlled release formulation of divalproex sodium
EP0231826B1 (en) Theophylline sustained release tablet
CA2182004C (en) Film coated tablet of paracetamol and domperidone
KR102742382B1 (ko) 경구 투약 제형
JP2011504455A (ja) 誤用抵抗性製剤
JPH0669965B2 (ja) 固体持続放出医薬製剤
JP2004203897A (ja) アルキル置換セルロースをベースとする持続放出性経口薬剤投与剤形
JPH0445B2 (enrdf_load_stackoverflow)
HK1207563A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
CN100544709C (zh) 抗血栓形成的化合物的可在口中分散的药物组合物
US20060147526A1 (en) Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines
CA1320133C (en) Analgesic drug comprising l-tryptophan
JPS6399007A (ja) 徐放性薬剤配合物の製造方法
TWI229609B (en) Pharmaceutical composition of orally administered controlled drug delivery system providing temporal and spatial control
JP2021187858A (ja) 医薬製剤